Royal Society Open ScienceSystems BiologyPeer-reviewed journal article
Bidirectional crosstalk between epithelial-mesenchymal plasticity and IFNγ-induced PD-L1 expression promotes tumor progression
Gerhard A. BurgeriD, Daphne NesenberendiD, Carlijn M. LemsiD, Sander C. HilleiD, Joost B. BeltmaniD
Abstract
Epithelial-Mesenchymal Transition (EMT) and immunoevasion through upregulation of Programmed Death-Ligand 1 (PD-L1) are important drivers of cancer progression. While EMT has been proposed to facilitate PD-L1-mediated immunosuppression, the molecular mechanisms of their interaction remain obscure. Here we provide insight into these mechanisms by proposing a mathematical model that describes the crosstalk between EMT and Interferon gamma (IFN{gamma})-induced PD-L1 expression. Our model shows that via interaction with microRNA-200 (miR-200), the multistability of the EMT regulatory circuit is mirrored in the PD-L1 levels, which are further amplified by IFN{gamma} stimulation. This IFN{gamma}-mediated effect is most prominent for cells in a fully mesenchymal state, and less strong for those in an epithelial or partially mesenchymal state. Additionally, bi-directional crosstalk between miR-200 and PD-L1 implies that IFN{gamma} stimulation allows cells to undergo EMT for lower amounts of inducing signal, and that IFN{gamma} presence accelerates EMT and decelerates Mesenchymal-Epithelial Transition (MET). Overall, our model agrees with published findings and provides insight into possible mechanisms behind EMT-mediated immune-evasion; and primary, adaptive, or acquired resistance to immunotherapy. Our model can be used as a starting point to explore additional crosstalk mechanisms, as an improved understanding of these mechanisms is indispensable for developing better diagnostic and therapeutic options for cancer patients. Graphical Abstract O_FIG O_LINKSMALLFIG WIDTH=200 HEIGHT=97 SRC="FIGDIR/small/478950v1_ufig1.gif" ALT="Figure 1"> View larger version (15K): org.highwire.dtl.DTLVardef@1e5fde0org.highwire.dtl.DTLVardef@7e929dorg.highwire.dtl.DTLVardef@1cb9f6borg.highwire.dtl.DTLVardef@14f50ad_HPS_FORMAT_FIGEXP M_FIG C_FIG Schematic overview of the crosstalk between Epithelial-Mesenchymal Transition (EMT) and Interferon gamma (IFN{gamma})-induced Programmed Death-Ligand 1 (PD-L1) expression. IFN{gamma}-induced PD-L1 expression promotes the occurrence of EMT. EMT, also induced by, for example, Transforming Growth Factor Beta (TGF{beta}), increases PD-L1 expression levels, facilitating tumor immunoevasion.
- Citations
- 11
- FWCI
- 1.05
- Field percentile
- top 22%
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Modeling the effects of EMT-immune dynamics on epithelial cancer progression
Daniel R. Bergman, Matthew K. Karikomi, … Adam L. MacLean·bioRxiv·May 30, 2020
- Immunosuppressive traits of the hybrid epithelial/mesenchymal phenotype
S. Sahoo, S. P. Nayak, … M. K. Jolly·bioRxiv·Jun 21, 2021
- PD-L1 activity is associated with partial EMT and metabolic reprogramming in carcinomas
S. Muralidharan, M. Sehgal, … M. K. Jolly·bioRxiv·Oct 5, 2022
- IFN-γ induces epithelial-to-mesenchymal transition of cancer cells via an unique microRNA processing
U-Ging Lo, Rey-Chen Pong, … Jer-Tsong Hsieh·bioRxiv·Jun 25, 2018
- Gli2 Facilitates Tumor Immune Evasion and Immunotherapeutic Resistance by Coordinating Wnt Ligand and Prostaglandin Signaling
N. C. DeVito, Y.-V. Nguyen, … B. A. Hanks·bioRxiv·Mar 31, 2024
- Tumor PD-L1 selectively suppresses type I interferon in myeloid cells to suppress CTL recruitment to promote lung metastasis
J. D. Klement, P. S. Redd, … K. Liu·bioRxiv·Jun 18, 2021